Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease

被引：8

作者：

He, Chuan ^{[1
]}

Huang, Zhong-sheng ^{[1
]}

Yu, Chao-chao ^{[2
,3
]}

Wang, Hai-hua ^{[4
]}

Zhou, Hua ^{[1
]}

Kong, Li-hong ^{[1
]}

机构：

[1] Hubei Univ Chinese Med, Wuhan 430060, Peoples R China

[2] Shenzhen Tradit Chinese Med Hosp, Dept Tuina, Shenzhen 518000, Peoples R China

[3] Guangzhou Univ Chinese Med, Clin Coll 4, Shenzhen 518000, Peoples R China

[4] Hosp Tradit Chinese Med Fengrun Dist, Tangshan 064000, Peoples R China

来源：

CURRENT MEDICAL SCIENCE | 2020年 / 40卷 / 06期

基金：

中国国家自然科学基金;

关键词：

Alzheimer's disease; amyloid-beta; epigenetics; DNA methylation; microRNAs; histone modifications; GENE-PROMOTER METHYLATION; PRECURSOR PROTEIN GENE; NON-CODING RNA; DNA METHYLATION; MOUSE MODEL; CEREBROSPINAL-FLUID; COGNITIVE DEFICITS; NONCODING RNA; UP-REGULATION; IN-VITRO;

D O I：

10.1007/s11596-020-2283-0

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Senile plaques (SPs) are one of the pathological features of Alzheimer's disease (AD) and they are formed by the overproduction and aggregation of amyloid-beta (A beta) peptides derived from the abnormal cleavage of amyloid precursor protein (APP). Thus, understanding the regulatory mechanisms during A beta metabolism is of great importance to elucidate AD pathogenesis. Recent studies have shown that epigenetic modulation-including DNA methylation, non-coding RNA alterations, and histone modifications-is of great significance in regulating A beta metabolism. In this article, we review the aberrant epigenetic regulation of A beta metabolism.

引用

页码：1022 / 1030

页数：9

共 50 条

[21] Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
Maria Luisa Moro
Andrew Stephen Phillips
Katie Gaimster
Christian Paul
Amritpal Mudher
James A. R. Nicoll
Delphine Boche
Acta Neuropathologica Communications, 6
[22] Lipid peroxidation and Alzheimer's disease: Key role of Amyloid-beta
Kontush, Anatol
OCL-OILSEEDS AND FATS CROPS AND LIPIDS, 2006, 13 (01) : 46 - 53
[23] Epigenetic regulation in the pathophysiology of Alzheimer's disease
Chouliaras, Leonidas
Rutten, Bart P. F.
Kenis, Gunter
Peerbooms, Odette
Visser, Pieter Jelle
Verhey, Frans
van Os, Jim
Steinbusch, Harry W. M.
van den Hove, Daniel L. A.
PROGRESS IN NEUROBIOLOGY, 2010, 90 (04) : 498 - 510
[24] Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease
Moro, Maria Luisa
Phillips, Andrew Stephen
Gaimster, Katie
Paul, Christian
Mudher, Amritpal
Nicoll, James A. R.
Boche, Delphine
ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2018, 6 : 3
[25] Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s disease
Evan Dorey
Nina Chang
Qing Yan Liu
Ze Yang
Wandong Zhang
Neuroscience Bulletin, 2014, 30 : 317 - 330
[26] Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain
Wildburger, Norelle C.
Esparza, Thomas J.
LeDuc, Richard D.
Fellers, Ryan T.
Thomas, Paul M.
Cairns, Nigel J.
Kelleher, Neil L.
Bateman, Randall J.
Brody, David L.
SCIENTIFIC REPORTS, 2017, 7
[27] PET amyloid-beta imaging in preclinical Alzheimer's disease
Vlassenko, Andrei G.
Benzinger, Tammie L. S.
Morris, John C.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (03): : 370 - 379
[28] Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease
Evan Dorey
Nina Chang
Qing Yan Liu
Ze Yang
Wandong Zhang
Neuroscience Bulletin, 2014, 30 (02) : 317 - 330
[29] Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy
Huber, Colin M.
Yee, Connor
May, Taylor
Dhanala, Apoorva
Mitchell, Cassie S.
JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (01) : 265 - 281
[30] Comparative analysis of multimodal biomarkers for amyloid-beta positivity detection in Alzheimer's disease cohorts
Ghazi, Mostafa Mehdipour
Selnes, Per
Timon-Reina, Santiago
Tecelao, Sandra
Ingala, Silvia
Bjornerud, Atle
Kirsebom, Bjorn-Eivind
Fladby, Tormod
Nielsen, Mads
FRONTIERS IN AGING NEUROSCIENCE, 2024, 16

← 1 2 3 4 5 →